| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| LPAL2 |
Q16609
|
lipoprotein(a) like 2, pseudogene
|
Enzyme
|
|
0.626 |
0.731 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| TAS2R12P |
|
taste 2 receptor member 12 pseudogene
|
|
|
0.861 |
0.154 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| HCCAT5 |
|
hepatocellular carcinoma associated transcript 5
|
|
|
0.716 |
0.462 |
| TTC28-AS1 |
|
TTC28 antisense RNA 1
|
|
|
0.890 |
0.192 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| CHKB-CPT1B |
|
CHKB-CPT1B readthrough (NMD candidate)
|
|
|
0.769 |
0.385 |
| SUMO4 |
Q6EEV6
|
small ubiquitin like modifier 4
|
|
|
0.653 |
0.577 |
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
| LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |
| MIR107 |
|
microRNA 107
|
|
|
0.543 |
0.769 |
| MIR10B |
|
microRNA 10b
|
|
|
0.509 |
0.808 |
| MIR122 |
|
microRNA 122
|
|
|
0.468 |
0.808 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR130A |
|
microRNA 130a
|
|
|
0.522 |
0.808 |
| MIR130B |
|
microRNA 130b
|
|
|
0.547 |
0.808 |